PL2222275T3 - Kompozycje farmaceutyczne zawierające antagonistów bradykininy i kwas hialuronowy, oraz ich zastosowanie - Google Patents

Kompozycje farmaceutyczne zawierające antagonistów bradykininy i kwas hialuronowy, oraz ich zastosowanie

Info

Publication number
PL2222275T3
PL2222275T3 PL08853047T PL08853047T PL2222275T3 PL 2222275 T3 PL2222275 T3 PL 2222275T3 PL 08853047 T PL08853047 T PL 08853047T PL 08853047 T PL08853047 T PL 08853047T PL 2222275 T3 PL2222275 T3 PL 2222275T3
Authority
PL
Poland
Prior art keywords
pharmaceutical compositions
hyaluronic acid
compositions containing
bradykinin antagonists
containing bradykinin
Prior art date
Application number
PL08853047T
Other languages
English (en)
Inventor
Carlo Alberto Maggi
Sandro Giuliani
Laura Quartara
Original Assignee
St Luso Farmaco Ditalia S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Luso Farmaco Ditalia S P A filed Critical St Luso Farmaco Ditalia S P A
Publication of PL2222275T3 publication Critical patent/PL2222275T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
PL08853047T 2007-11-23 2008-11-10 Kompozycje farmaceutyczne zawierające antagonistów bradykininy i kwas hialuronowy, oraz ich zastosowanie PL2222275T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT002225A ITMI20072225A1 (it) 2007-11-23 2007-11-23 "composizioni farmaceutiche a base di antagonisti della bradichinina ed acido ialuronico e loro uso"
EP08853047A EP2222275B1 (en) 2007-11-23 2008-11-10 Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid, and uses thereof
PCT/EP2008/009451 WO2009065507A2 (en) 2007-11-23 2008-11-10 Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid, and uses thereof

Publications (1)

Publication Number Publication Date
PL2222275T3 true PL2222275T3 (pl) 2012-03-30

Family

ID=40314753

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08853047T PL2222275T3 (pl) 2007-11-23 2008-11-10 Kompozycje farmaceutyczne zawierające antagonistów bradykininy i kwas hialuronowy, oraz ich zastosowanie

Country Status (41)

Country Link
US (1) US9101627B2 (pl)
EP (1) EP2222275B1 (pl)
JP (1) JP5383695B2 (pl)
KR (1) KR101585868B1 (pl)
CN (1) CN101868225B (pl)
AP (1) AP2628A (pl)
AR (1) AR069407A1 (pl)
AT (1) ATE529096T1 (pl)
AU (1) AU2008328311B2 (pl)
BR (1) BRPI0820402A2 (pl)
CA (1) CA2706398C (pl)
CL (1) CL2008003475A1 (pl)
CO (1) CO6270301A2 (pl)
CR (1) CR11457A (pl)
CY (1) CY1112134T1 (pl)
DK (1) DK2222275T3 (pl)
EA (1) EA017626B1 (pl)
EC (1) ECSP10010153A (pl)
ES (1) ES2374861T3 (pl)
GE (1) GEP20125602B (pl)
HK (1) HK1149714A1 (pl)
HN (1) HN2010001037A (pl)
HR (1) HRP20110904T1 (pl)
IL (1) IL205860A (pl)
IT (1) ITMI20072225A1 (pl)
MA (1) MA31913B1 (pl)
MX (1) MX2010005484A (pl)
MY (1) MY148685A (pl)
NI (1) NI201000087A (pl)
NZ (1) NZ585514A (pl)
PA (1) PA8804801A1 (pl)
PE (1) PE20091422A1 (pl)
PL (1) PL2222275T3 (pl)
PT (1) PT2222275E (pl)
RS (1) RS52045B (pl)
SI (1) SI2222275T1 (pl)
TN (1) TN2010000215A1 (pl)
TW (1) TWI448292B (pl)
UA (1) UA97867C2 (pl)
WO (1) WO2009065507A2 (pl)
ZA (1) ZA201003586B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3153156A4 (en) * 2014-05-30 2018-02-14 Derkach, Nataliia Mykolaivna Composition based on a stabilized solution of active ingredients
EP3238728B1 (en) 2014-12-26 2020-09-02 Seikagaku Corporation Agent comprising hyaluronic acid having an aminoalkyl cinnamate covalently bonded thereto for improving subjective symptoms in eyes
US11401303B2 (en) * 2020-06-15 2022-08-02 Taian City Qihang Biotechnology Co. Synthetic peptide BRAP and application in preparation of anti-inflammatory drug for COVID-19 thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7635489B2 (en) * 2001-05-18 2009-12-22 Leneau Holdings, Llc Ingestion of hyaluronic acid for improved joint health
ITMI20021247A1 (it) * 2002-06-07 2003-12-09 Menarini Ricerche Spa Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche
ITMI20041963A1 (it) * 2004-10-15 2005-01-15 Luso Farmaco Inst "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche"

Also Published As

Publication number Publication date
EA201000678A1 (ru) 2010-12-30
US9101627B2 (en) 2015-08-11
PT2222275E (pt) 2012-01-16
ITMI20072225A1 (it) 2009-05-24
DK2222275T3 (da) 2012-01-02
MA31913B1 (fr) 2010-12-01
JP5383695B2 (ja) 2014-01-08
NZ585514A (en) 2012-01-12
CA2706398C (en) 2016-07-05
HN2010001037A (es) 2012-12-10
MX2010005484A (es) 2010-06-07
TW200927151A (en) 2009-07-01
ATE529096T1 (de) 2011-11-15
RS52045B (en) 2012-04-30
CA2706398A1 (en) 2009-05-28
US20100292156A1 (en) 2010-11-18
PE20091422A1 (es) 2009-10-17
ZA201003586B (en) 2011-08-31
PA8804801A1 (es) 2009-06-23
CO6270301A2 (es) 2011-04-20
CY1112134T1 (el) 2015-11-04
MY148685A (en) 2013-05-31
SI2222275T1 (sl) 2012-01-31
GEP20125602B (en) 2012-08-10
TWI448292B (zh) 2014-08-11
KR101585868B1 (ko) 2016-01-22
UA97867C2 (ru) 2012-03-26
IL205860A0 (en) 2010-11-30
TN2010000215A1 (en) 2011-11-11
CN101868225A (zh) 2010-10-20
NI201000087A (es) 2011-07-18
WO2009065507A3 (en) 2009-09-03
ECSP10010153A (es) 2010-06-29
JP2011504473A (ja) 2011-02-10
EP2222275B1 (en) 2011-10-19
AU2008328311A1 (en) 2009-05-28
CR11457A (es) 2010-11-05
CL2008003475A1 (es) 2009-03-27
AU2008328311B2 (en) 2013-02-28
IL205860A (en) 2013-01-31
CN101868225B (zh) 2013-06-12
BRPI0820402A2 (pt) 2015-05-19
ES2374861T3 (es) 2012-02-22
WO2009065507A2 (en) 2009-05-28
AP2628A (en) 2013-03-26
AP2010005265A0 (en) 2010-06-30
KR20100096106A (ko) 2010-09-01
HK1149714A1 (en) 2011-10-14
EP2222275A2 (en) 2010-09-01
EA017626B1 (ru) 2013-01-30
HRP20110904T1 (hr) 2011-12-31
AR069407A1 (es) 2010-01-20

Similar Documents

Publication Publication Date Title
IL247741A0 (en) pharmaceutical preparations
IL242883B (en) Aryl-amino and heteroaryl-amino converted deoxazolines and pharmaceutical preparations containing them
IL215799A (en) Quinazolone compounds, pharmaceuticals containing them and their uses
IL216254A (en) Compounds, pharmaceutical compositions and their uses
IL214175A (en) Derivatives of aminotetralin, their pharmaceutical compositions and their use
IL206395A (en) N- Heterocyclic-7-Oxo-6-Sulphoxy-6,1-Diazabicyclo [1.2.3] Octane-2-Carboxamides and Pharmaceuticals Containing Them
IL200206A0 (en) Quinoxaline darivatives, their preparation and pharmaceutical compositions containing them
IL204844A (en) Coinolone analogues, pharmaceuticals containing them and their uses
EP2056835A4 (en) PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
EP2222313A4 (en) PHARMACEUTICAL COMPOSITIONS
IL206808A (en) Indolyl-pyridone history, their pharmaceutical preparations and their uses
ZA201200367B (en) Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
EP2241569A4 (en) THIENOPYRIDAZINE COMPOUNDS, PREPARATIONS THEREOF, PHARMACEUTICAL COMPOSITIONS AND USES
IL217500A0 (en) Tetrazole derivatives, their preparartion and pharmaceutical compositions containing them
IL213452A0 (en) Phenylpyrimidone compounds, pharmaceutical compositions, preparation methods and uses thereof
PT2193795E (pt) Composição farmacêutica aquosa contendo latanoprost
EP2146695A4 (en) PHARMACEUTICAL COMPOSITIONS
GB0709811D0 (en) Pharmaceutical compositions
GB0707127D0 (en) Pharmaceutical compositions
IL212171A (en) 1-Phenylpyrol compounds, pharmaceuticals containing them and their use
HK1149714A1 (en) Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid, and uses thereof
IL201912A0 (en) Aqueous pharmaceutical composition
GB0712454D0 (en) Pharmaceutical compositions
GB2454923B (en) Pharmaceutical compositions
IL201394A0 (en) Niacin - based pharmaceutical compositions